Southwick's angle determination during Growth hormone treatment and its usefulness to evaluate risk of epiphysiolysis

Journal of Pediatric Orthopaedics Part B

Volumn 18, Issue 1, 2009, Pages 11-15

  De Andrade, Anenisia Coelho ^a,c   Longui, Carlos Alberto ^a   Damasceno, Francisco L V ^b   Santili, Cläudio ^b  

^a Pediatric Endocrinology Unit   (Brazil)

^b FACULDADE DE CIÊNCIAS MÉDICAS DA SANTA CASA DE SÃO PAULO   (Brazil)

^c NONE   (Brazil)

Author keywords

Epiphysiolysis; Growth hormone deficiency; Slipped capital femoral epiphysis; Southwick's angle

Indexed keywords

HUMAN GROWTH HORMONE;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIAPHYSIS; EPIPHYSIOLYSIS; EPIPHYSIS; FEMALE; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; MALE; MUSCULOSKELETAL SYSTEM PARAMETERS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; SIDE EFFECT; SOUTHWICK ANGLE; TREATMENT OUTCOME;

ADOLESCENT; CASE-CONTROL STUDIES; CHILD; DWARFISM, PITUITARY; EPIPHYSES, SLIPPED; FEMALE; FEMUR HEAD; HIP JOINT; HUMAN GROWTH HORMONE; HUMANS; MALE;

EID: 67649172211     PISSN: 1060152X     EISSN: 14735865     Source Type: Journal    
DOI: 10.1097/BPB.0b013e328318c6f3     Document Type: Article

References (18)

1. Blethen SL, Rundle AC. Slipped capital femoral epiphysis in children treated with growth hormone. A summary of the National Cooperative Growth Study experience. Horm Res 1996; 46:113-116.
2. Rappaport EB, Fife D. Slipped capital femoral epiphysis in growth hormonedeficient patients. Am J Dis Child 1985; 139:396-399.
3. Clayton PE, Cowell CT. Safety issues in children and adolescents during growth hormone therapy: a review. Growth Horm IGF Res 2000; 10:306-317.
4. Kelsey JL. The incidence and distribution of slipped capital femoral epiphysis in Connecticut. J Chronic Dis 1971; 23:567-578.
5. Henrikson B. The incidence of slipped capital femoral epiphysis. Acta Orthop Scand 1969; 40:365-372.
6. Rappaport EB, Snoy P, Habig WH, Bright RW. Effects of exogenous growth hormone on growth plate cartilage in rats. Am J Dis Child 1987; 141: 497-501.
7. Cowell CT, Dietsch S. Adverse events during growth hormone therapy. J Pediatr Endocrinol Metab 1995; 8:243-252.
8. Hollingworth P. Differential diagnosis and management of hip pain in childhood. Br J Rheumatol 1995; 34:78-82.
9. Ingram AJ, Clarke MS, Clarke CS Jr, Marshall WR. Chondrolysis complicating slipped capital femoral epiphysis. Clin Orthop Relat Res 1982; 165:99-109.
10. Loder RT, Aronson DD, Greenfield ML. The epidemiology of bilateral slipped capital femoral epiphysis. A study of children in Michigan. J Bone Joint Surg Am 1993; 75:1141-1147.
11. Loder RT. The demographics of slipped capital femoral epiphysis. An international multicenter study. Clin Orthop Relat Res 1996; 322:8-27.
12. Southwick WO. Osteotomy through the lesser trochanter for slipped capital femoral epiphysis. J Bone Joint Surg Am 1967; 49:807-835.
13. Santili C, De Assis MC, Kusabara FI, Romero IL, Sartini CM, Longui CA. Southwick's head-shaft angles: normal standards and abnormal values observed in obesity and in patients with epiphysiolysis. J Pediatr Orthop B 2004; 13:244-247.
14. Damaceno FL, Santili C, Longui CA. Normal reference values of Southwick's anteroposterior angle in prepubertal and pubertal normal adolescents. J Pediatr Orthop B 2007; 16:389-392.
15. Futami T, Suzuki S, Seto Y, Kashiwagi N. Sequential magnetic resonance imaging in slipped capital femoral epiphysis: assessment of preslip in the contralateral hip. J Pediatr Orthop B 2001; 10:298-303.
16. Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child 1969; 44:291-303.
17. Wells D, King JD, Roe TF, Kaufman FR. Review of slipped capital femoral epiphysis associated with endocrine disease. J Pediatr Orthop 1993; 13:610-614.
18. Wilton P. Adverse events during growth hormone treatment: 5 years experience in the Kabi International Growth Study. In: Gunnarsson R, Ma R, editors. Progress in growth hormone therapy - 5 years of KIGS. Mannheim: J and J Verlag; 1994. pp. 291-307.